OTC:AAWH
Ascend Wellness Holdings, Inc.
AAWH is a vertically integrated cannabis concentrate manufacturer and accessory retailer driving double-digit revenue growth through premium product innovation.
Key Metrics
Investment Thesis
Bull Case
AAWH offers compelling growth potential due to its expanding market share in the high-growth cannabis sector and a diversified revenue stream that includes stable accessory sales. The company's strong cash position allows it to execute an aggressive M&A strategy, potentially acquiring distressed competitors at attractive valuations to consolidate market leadership. As the industry matures, AAWH's brand loyalty and production efficiency should drive margin expansion and profitability.
Bear Case
The stock carries deep valuation concerns given the persistent net losses and a massive retained earnings deficit that suggests historical profitability challenges or aggressive accounting adjustments. High debt issuance ($217.4M) coupled with significant repayments indicates ongoing refinancing pressure that could restrict financial flexibility if market conditions tighten. Regulatory uncertainty remains a primary threat, as any adverse changes in state laws or federal policy could severely impact the entire business model.
About Ascend Wellness Holdings, Inc.
Ascend Wellness Holdings, Inc. (AAWH) is a leading manufacturer of premium cannabis concentrates and accessories serving the regulated markets across North America. The company leverages its vertically integrated supply chain to produce high-margin distillate products while expanding its retail accessory portfolio. With robust revenue growth from $405.9M in 2022 to $561.6M in 2024, AAWH is positioning itself as a dominant player in the evolving legal cannabis sector.
Analysis
Management Discussion
While revenue surged by 38% over three years, the company reported a net loss of $85.0M in 2024, highlighting the pressure from high operating expenses and significant non-cash adjustments totaling $81.3M. The cash flow from operations was positive at $73.3M, indicating strong underlying liquidity despite the bottom-line losses, supported by a healthy current asset base of $229.4M against $144.5M in current liabilities.
Industry Overview
The legal cannabis industry is transitioning from a high-growth exploration phase to a maturation phase characterized by consolidation and operational efficiency. Companies with vertical integration and strong brand equity are expected to outperform smaller players unable to achieve economies of scale. The sector continues to be heavily influenced by state-level taxation policies and banking restrictions, creating a unique risk-reward profile for investors.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | $405.9M | $518.6M | $561.6M |
| Cost of Revenue | $271.4M | $363.5M | $377.4M |
| Gross Profit | $134.6M | $155.1M | $184.2M |
| Operating Expenses | $142.1M | $158.7M | $179.5M |
| Operating Income | $-7.5M | $-3.6M | $4.7M |
| G&A | $137.1M | $158.7M | $179.5M |
| Stock-Based Comp | $19.0M | $19.8M | $18.6M |
| D&A | $37.1M | $59.0M | $66.2M |
| Depreciation | $25.4M | $34.2M | $36.8M |
| Amortization | $9.8M | $23.6M | $27.1M |
| Other OpEx | $5.0M | $0 | $0 |
| Non-Operating Income | $-31.7M | $-11.1M | $-44.6M |
| Interest Expense | $32.4M | $37.0M | — |
| Pre-Tax Income | $-39.2M | $-14.8M | $-39.8M |
| Income Tax | $41.7M | $33.5M | $45.2M |
| Continuing Ops | $-80.9M | $-48.2M | $-85.0M |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $-80.9M | $-48.2M | $-85.0M |
| Minority Interest | $0 | $0 | $0 |
| Net to Common | $-80.9M | $-48.2M | $-85.0M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Current Assets | $198.7M | $228.9M | $229.4M |
| Cash & Equivalents | $74.1M | $72.5M | $88.3M |
| Accounts Receivable | $14.1M | $28.3M | $36.5M |
| Inventory | $97.5M | $95.3M | $89.6M |
| Other Current Assets | $13.0M | $32.8M | $15.0M |
| Long-Term Assets | $673.4M | $690.7M | $671.1M |
| Goodwill | $44.4M | $47.5M | $49.6M |
| Operating Leases | $108.8M | $130.6M | $139.1M |
| Other LT Assets | $520.2M | $512.6M | $482.4M |
| Total Assets | $872.2M | $919.5M | $900.4M |
| Current Liabilities | $110.9M | $92.7M | $144.5M |
| Accounts Payable | $17.1M | $34.7M | $26.4M |
| Current Leases | $2.6M | $3.7M | $5.5M |
| Deferred Revenue | $672.0K | $1.3M | $1.4M |
| Taxes Payable | $34.7M | $0 | $696.0K |
| Other Current Liab | $55.9M | $53.0M | $110.6M |
| Long-Term Liabilities | $597.8M | $684.0M | $684.1M |
| LT Operating Leases | $229.8M | $261.1M | $267.2M |
| Other LT Liab | $368.0M | $422.9M | $416.9M |
| Total Liabilities | $708.7M | $776.7M | $828.6M |
| Shareholders' Equity | $163.4M | $142.9M | $71.8M |
| Paid-In Capital | $430.4M | $458.0M | $471.1M |
| Retained Earnings | $-267.1M | $-315.4M | $-400.4M |
| Total L&E | $872.2M | $919.5M | $900.4M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net Income (CFO) | $-80.9M | $-48.2M | $-85.0M |
| Non-Cash Adjustments | $-11.1M | $18.9M | $81.3M |
| Working Capital Changes | $53.6M | $104.7M | $77.0M |
| Cash from Operations | $-38.4M | $75.3M | $73.3M |
| Capital Expenditures | $81.6M | $24.2M | $22.5M |
| Cash from Investing | $-114.3M | $-59.9M | $-37.2M |
| Debt Issuances | $84.4M | $0 | $217.4M |
| Debt Repayments | $3.1M | $23.2M | $215.8M |
| Cash from Financing | $71.3M | $-17.1M | $-20.4M |
| FX Effect | $0 | $0 | $0 |
| Net Change in Cash | $-81.3M | $-1.6M | $15.7M |
| Beginning Cash | $155.5M | $74.1M | $72.5M |
| Ending Cash | $74.1M | $72.5M | $88.3M |
Frequently Asked Questions
How does Ascend Wellness Holdings, Inc. make money?
The company's revenue is primarily driven by two core segments: high-margin cannabis concentrate manufacturing (including distillate, live resin, and diamond) and a growing accessories division selling branded glassware and vaporizers. A smaller portion of revenue comes from wholesale distribution partnerships with other licensed operators in key states like California and Illinois.
What are the main risks for AAWH?
Investors face significant regulatory risk as cannabis laws continue to evolve unpredictably across different U.S. states and federal jurisdictions. The company carries a substantial retained earnings deficit of $400.4M, which could limit future dividend capabilities or necessitate equity dilution to fund operations. Heavy capital expenditures ($22.5M) and high operating expenses ($179.5M) suggest thin profit margins that are sensitive to any shifts in market demand or tax policy changes.
What is AAWH's competitive advantage?
AAWH possesses significant cost advantages through its vertically integrated model that controls extraction, refinement, and packaging, shielding it from volatile raw material markups. The company benefits from a strong brand reputation for quality and consistency, allowing premium pricing power in competitive markets. Additionally, AAWH has substantial cash reserves ($88.3M) providing ample liquidity to fund strategic acquisitions and R&D without relying on high-cost debt.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.